Terminal agitation most commonly appears within the last 24 to 48 hours of life, and for many patients it lasts somewhere in that same window, though the range is wide enough that some people experience it for only a few hours while others endure it for several days. Published estimates of how often it occurs vary enormously, from under 2 percent to as high as 85 percent of dying patients, which hints at a deeper problem: clinicians do not even share a single agreed-upon definition of what terminal agitation is. That lack of consensus makes pinning down a precise timeline difficult, but the clinical picture is consistent enough to be useful for families trying to understand what is happening and what comes next.
The Typical Timeline
The phrase “terminal agitation” describes a cluster of restlessness, confusion, and distress that emerges as death approaches. The broadest consensus in the palliative care literature places onset within the final one to two days of life, and most episodes resolve either with medical management or when the person dies.1West Chester University Digital Commons. Identifying Predictive Factors of Terminal Agitation in Hospice Patients: A Retrospective Study In one large retrospective review of nearly 3,900 patients in their terminal phase, the median survival from the point when continuous sedative infusions were started was about 47 hours, and patients who received only as-needed doses had a median survival of about 27 hours.2PubMed Central. Pharmacological Treatment for Terminal Agitation, Delirium and Anxiety in Frail Older Patients Those numbers offer a rough proxy: once agitation is severe enough to need medication, death typically follows within one to two days, though individual cases can be shorter or longer.
Some patients experience a brief episode lasting just a few hours, often late in the dying process when consciousness is already fading. Others cycle in and out of agitated states over two or three days. Rarely, restlessness appears earlier, perhaps three to five days before death, particularly in patients with certain brain-affecting conditions or severe metabolic disturbances. There is no reliable way to predict exactly how long any individual episode will last, which is one of the most distressing aspects for families at the bedside.
Why the Prevalence Estimates Are All Over the Map
If you look up how common terminal agitation is, the numbers seem contradictory. Some references cite a range of 25 to 85 percent of dying patients, while at least one older hospice survey estimated the rate at just 1 to 2 percent.1West Chester University Digital Commons. Identifying Predictive Factors of Terminal Agitation in Hospice Patients: A Retrospective Study3OMEGA – Journal of Death and Dying. Terminal Restlessness in the Dying: Hospice Attitudes and Practice That gap is not a sign that nobody knows what they are talking about. It reflects the fact that “terminal agitation” is not a single, cleanly defined diagnosis. Some researchers count only the most severe, unmistakable episodes of thrashing and moaning. Others include any restlessness, fidgeting, or subtle confusion in the final days. The term is used interchangeably with “terminal delirium” and “terminal restlessness” in many settings, even though these may represent overlapping but distinct phenomena.
Hospice clinicians themselves acknowledge this inconsistency. A qualitative study of hospice staff found that many workers use the term loosely, and that the absence of a standard definition makes it hard to know whether two nurses documenting “terminal restlessness” are even describing the same thing.4PubMed Central. Hospice Clinicians’ Approaches to Terminal Restlessness: A Qualitative Analysis For families, the takeaway is that your loved one’s experience may not match the textbook descriptions perfectly, and that is normal. What matters more than the label is whether the person’s distress is being assessed and treated.
What Terminal Agitation Looks Like
Terminal agitation can be quiet or dramatic, and the form it takes often changes over time. The outward signs tend to include some combination of:
- Physical restlessness: pulling at bedsheets or clothing, attempting to climb out of bed, repetitive movements like plucking at the air or picking at skin.
- Vocal distress: moaning, calling out, or repeating words or phrases that may or may not make sense in context.
- Confusion: not recognizing familiar people, talking to people who are not present, appearing frightened or disoriented.
- Resistance to care: pushing away hands, pulling out IV lines or catheters, becoming combative during repositioning.
Not every patient shows all of these signs, and intensity can fluctuate from hour to hour. Some people have periods of relative calm between bursts of agitation. Others have a more sustained state of restlessness that gradually deepens as they move closer to death. The fluctuating nature makes it especially hard for families to gauge whether things are getting worse or whether this is just part of the normal pattern.
What Drives Terminal Agitation
The underlying causes are usually a tangle of several things happening simultaneously as the body shuts down. At the most basic level, the brain is losing its steady supply of oxygen, glucose, and the chemical balance it needs to function normally. This kind of diffuse metabolic failure has long been considered the central driver of delirium at the end of life, involving disrupted blood flow, abnormal energy metabolism, and breakdowns in neurotransmitter signaling.5PubMed Central. The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice As organs fail, toxins that the kidneys or liver would normally clear start accumulating in the blood and cross into the brain.
Medications themselves can contribute. Opioids, which are commonly used for pain and breathing comfort in the final days, can produce a syndrome of neurotoxicity when their metabolites build up. Symptoms of opioid-induced neurotoxicity include delirium, muscle twitching, heightened sensitivity to pain, and restlessness that can look exactly like terminal agitation.6PubMed Central. Opioid-induced neurotoxicity High doses, kidney impairment, and dehydration all raise the risk. This distinction matters because opioid-related restlessness is sometimes reversible if the dose is reduced or the opioid is switched to a different one, while agitation caused by organ failure generally is not.
Other potentially reversible triggers include a full bladder (urinary retention is surprisingly common in bedbound patients), uncontrolled pain that the patient can no longer report verbally, constipation, infection, or medication side effects from drugs other than opioids. Hospice clinicians consistently emphasize the importance of ruling out these fixable causes before concluding that agitation is truly terminal and irreversible.4PubMed Central. Hospice Clinicians’ Approaches to Terminal Restlessness: A Qualitative Analysis
Reversible Versus Irreversible Agitation
This is the single most important clinical distinction, and it directly affects how long the agitation lasts. If a reversible cause is identified and corrected, such as placing a catheter for a distended bladder or rotating to a different opioid, the restlessness can ease within minutes to hours. In those cases, what looked like terminal agitation may have been a treatable medical problem all along.
Irreversible agitation, on the other hand, tends to persist until either medications bring it under control or the dying process overtakes it. This is the form most families are asking about when they search for how long terminal agitation lasts. When organ failure is advanced and the brain is no longer receiving what it needs, the agitation typically continues, with fluctuations, until the person becomes too deeply unconscious for it to manifest outwardly. In practical terms, that often means a period of hours to a day or two, though occasionally longer.
The challenge for the care team is that these two categories can look identical at the bedside. A person pulling at their gown might be confused from metabolic encephalopathy or simply in pain from a full bladder. Experienced hospice clinicians describe working through a mental checklist of reversible causes before assuming the situation is irreversible.4PubMed Central. Hospice Clinicians’ Approaches to Terminal Restlessness: A Qualitative Analysis That process can sometimes feel slow to families who are watching their loved one in distress, but it helps ensure that a fixable problem is not being masked with sedation.
How Agitation Is Measured and Tracked
One reason clinicians have struggled to give families firm timelines is that, until recently, there was no widely accepted scale designed specifically for rating terminal agitation. Tools borrowed from intensive care settings, like the Richmond Agitation-Sedation Scale, have been adapted for palliative care. A pilot study of one such adaptation, the RASS-PAL, found preliminary evidence that it could reliably capture agitation and sedation levels in palliative care patients when used by both physicians and nurses.5PubMed Central. The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice More recently, researchers have used expert consensus methods to develop a four-point severity scale specifically for terminal agitation, validated against clinical scenarios rated by experienced palliative care professionals.7PubMed. Terminal agitation: the Delphi method for a symptom severity measurement tool
These tools are still relatively new and not yet universal in hospice settings. In many cases, the assessment remains somewhat subjective, relying on a nurse’s or physician’s experienced eye and a family member’s account of what has changed. If you are caring for someone at home with hospice support, it helps to note patterns: when agitation seems worst (night is common), what seems to soothe it even briefly, and whether it appears to be escalating or holding steady. That information gives the clinical team something concrete to work with when deciding whether to adjust medications.
Medications Used to Manage Terminal Agitation
The goal of treatment is not to cure the agitation, since its root cause in most terminal cases is irreversible organ failure. The goal is to relieve suffering. Two categories of medication dominate.
Haloperidol, a low-dose antipsychotic, is recommended in many guidelines as a first-line treatment for delirium in the dying. It can help with confusion, hallucinations, and some forms of agitated restlessness. However, the evidence base for its effectiveness in this specific population is thin. A review of pharmacological treatments for terminal agitation in frail older patients concluded that haloperidol is widely used but that high-quality evidence about how well it actually works is missing.2PubMed Central. Pharmacological Treatment for Terminal Agitation, Delirium and Anxiety in Frail Older Patients Clinicians use it because decades of clinical experience suggest it helps, not because robust trials have proven it.
Midazolam, a fast-acting benzodiazepine, is considered one of the four essential drugs for quality care in dying patients.8PubMed Central. Midazolam: an essential palliative care drug It works primarily as a sedative, calming physical restlessness and reducing the conscious experience of distress. A randomized trial comparing intranasal midazolam with the standard subcutaneous injection found that both routes produced a significant drop in agitation scores within five minutes, with further reduction by 20 minutes. Every patient in the trial achieved a meaningful reduction in agitation regardless of which route was used.9PubMed Central. A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study) The intranasal option is particularly useful for caregivers at home, since it does not require an injection.
In the large retrospective study mentioned earlier, midazolam was by far the most commonly used medication in the terminal phase, administered in over 90 percent of cases across three hospice settings. Haloperidol and levomepromazine (another sedating antipsychotic) were used much less frequently.2PubMed Central. Pharmacological Treatment for Terminal Agitation, Delirium and Anxiety in Frail Older Patients In practice, many patients receive a combination: haloperidol for the delirium component and midazolam for the restlessness and anxiety.
When Standard Treatment Does Not Work
Some episodes of terminal agitation do not respond adequately to standard doses of haloperidol or midazolam. When agitation persists despite escalating medication, clinicians describe it as refractory. This is the scenario families dread most: the person remains visibly distressed despite everything the team is trying.
The usual next step is proportionate palliative sedation, where sedative doses are increased with the explicit goal of reducing the patient’s level of consciousness enough to relieve suffering. This is not the same as euthanasia, a distinction that matters both ethically and practically. The intent is comfort, not hastening death, and doses are titrated to the minimum level needed to control symptoms. Most palliative care guidelines around the world support this approach for refractory symptoms at the end of life.
From a timeline perspective, refractory agitation that requires deep sedation tends to occur in the last day or two of life. Once adequate sedation is achieved, the person typically appears peaceful, and death follows within hours to a couple of days. Families often describe the moment sedation takes effect as an enormous relief, both for the patient and for themselves, even when they feel conflicted about the decision.
What Families Experience at the Bedside
Terminal agitation is often more traumatic for the people watching than for the person dying, though that is a cold comfort in the moment. The confusion means the patient may not recognize loved ones, may say things that are out of character, or may appear frightened of things that are not there. Families frequently describe feeling helpless, guilty about wanting the person to “just be at peace,” and uncertain about whether the medications are helping or making things worse.
Communication from the care team makes an enormous difference. Research into palliative care communication for degenerative conditions has found that the onset of agitation is one of the key topics families need discussed proactively, alongside pain management and sedation decisions.10PubMed Central. Communicating in Palliative Care for Neurodegenerative Diseases: A Qualitative Study on Professional–Family Interactions When families are warned ahead of time that agitation may happen, understand that it is a recognized part of dying, and know what the plan is if it occurs, they tend to cope better than families who encounter it with no preparation.
A few practical things can help in the moment. Keeping the room quiet and dimly lit reduces sensory overload. Speaking in a calm, low voice, even if the person does not seem to understand, can be soothing. Gentle touch, like holding a hand or stroking a forehead, sometimes brings brief periods of calm. Playing soft, familiar music has anecdotal support. Avoiding unnecessary repositioning or medical interventions that might provoke combativeness is usually wise once the focus has shifted entirely to comfort.
The Question Underneath the Question
When people search for how long terminal agitation lasts, they are often really asking something harder: how much longer does my loved one have? The honest answer is that terminal agitation is a strong signal that death is near, almost always within days, and frequently within hours to a day or two. It is one of the most reliable indicators that the active dying phase has begun. Other signs that tend to appear in the same window include mottled skin on the extremities, changes in breathing patterns (including the irregular Cheyne-Stokes pattern), decreasing blood pressure, and progressive unresponsiveness.
No one can predict the exact moment of death, and clinicians who have done this work for decades will tell you they have been surprised in both directions. But when a person who has been gradually declining suddenly becomes agitated and confused in the ways described above, the most likely trajectory is that you are looking at a timeline measured in hours to a couple of days, not weeks. If the hospice team has not already been called, this is the time to call them. If they are already involved, this is the time to ask about the medication plan and make sure the people who want to be present are nearby.
Why the Science Is Still Playing Catch-Up
It is striking how little high-quality research exists on something this common and this distressing. Terminal agitation sits at an awkward intersection of research ethics and practical difficulty. Running a placebo-controlled trial on a dying person in distress raises obvious moral concerns. Enrollment is difficult because the onset is unpredictable, patients cannot consent for themselves, and the window for studying the condition is extremely short. The result is a literature dominated by retrospective chart reviews, case series, and expert opinion, with very few randomized trials.
The lack of a standardized definition compounds the problem. Researchers studying “terminal agitation,” “terminal restlessness,” and “terminal delirium” may be measuring overlapping but different phenomena, making it hard to pool results across studies. Efforts to build validated severity scales are a step toward fixing this.7PubMed. Terminal agitation: the Delphi method for a symptom severity measurement tool If clinicians can agree on what they are measuring, future studies will produce more consistent answers about how long it lasts, what predicts its onset, and which treatments work best. For now, though, families and clinicians are working with rough patterns and clinical judgment rather than precise data, and being honest about that uncertainty is part of providing good care.